GlaxoSmithKline PLC is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi. Andrew Witty has been the chief executive officer since 2008. Emma Walmsley became CEO on 31 March 2017 and is the first female CEO of the company.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of August 2016 it had a market capitalisation of £81 billion, the fourth largest on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange.
GSK's drugs and vaccines earned £21.3 billion in 2013. Its top-selling products that year were Advair, Avodart, Flovent, Augmentin, Lovaza and Lamictal. GSK's consumer products, which earned £5.2 billion in 2013, include Sensodyne and Aquafresh toothpaste, the malted-milk drink Horlicks, Abreva for cold sores, Breathe Right nasal strips, Nicoderm and Nicorette nicotine replacements, and Night Nurse, a cold remedy. The company developed the first malaria vaccine, RTS,S, which it said in 2014 it would make available for five percent above cost. Legacy products developed at GSK include several listed in the World Health Organization Model List of Essential Medicines, such as amoxicillin, mercaptopurine, pyrimethamine and zidovudine.
|Products||Pharmaceuticals, vaccines, oral healthcare, nutritional products, over-the-counter medicines|
|Predecessor||Glaxo plc Wellcome plc Beecham Group plc Kline & French Beckman Companies Smith plc|
|Key people||Sir Philip Hampton (Chairman) Emma Walmsley (CEO)|
|Industry||Pharmaceutical Biotechnology Consumer goods|
|Founded||December 2000; 16 years ago (2000-12)|
NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.
It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.
The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.
Net Promoter Score is a number from -100 from 100.
Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.
The industry average for Health Care / Major Pharmaceuticals is 0.
The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.
Consider an example: If GlaxoSmithKline PLC sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.
On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.
Therefore, comparing the NPS score of GlaxoSmithKline PLC with your own without any further context is not that useful.
What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.
|CIGNA||Insurance / Health and Life Insurance||-1|
|Vodafone||Telecommunications / Wireless Carrier||-1|
|Chase||Financial Services / Banking||-1|
|Cleeng||Technology / Software||1|
|Fifth Third Bank||Financial Services / Banking||1|
|Accenture Consulting||Technology / Other||1|
|Dish||Telecommunications / Cable/TV service||1|
|Morrisons||Consumer Brands / Grocery||2|
|Mediacom||Consumer Brands / Entertainment||2|
|ESPN||Consumer Brands / Entertainment||2|
We have estimated the Net Promoter Score of GlaxoSmithKline PLC based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.